| Product Code: ETC6167868 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Armenia Pulmonary Arterial Hypertension Market Overview |
3.1 Armenia Country Macro Economic Indicators |
3.2 Armenia Pulmonary Arterial Hypertension Market Revenues & Volume, 2021 & 2031F |
3.3 Armenia Pulmonary Arterial Hypertension Market - Industry Life Cycle |
3.4 Armenia Pulmonary Arterial Hypertension Market - Porter's Five Forces |
3.5 Armenia Pulmonary Arterial Hypertension Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Armenia Pulmonary Arterial Hypertension Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Armenia Pulmonary Arterial Hypertension Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
4 Armenia Pulmonary Arterial Hypertension Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about pulmonary arterial hypertension (PAH) among healthcare professionals and patients |
4.2.2 Technological advancements in the diagnosis and treatment of PAH |
4.2.3 Growing prevalence of risk factors such as obesity and smoking leading to an increase in PAH cases |
4.3 Market Restraints |
4.3.1 High cost associated with the treatment of PAH |
4.3.2 Limited access to specialized healthcare facilities for PAH diagnosis and management |
4.3.3 Stringent regulatory requirements for approval of PAH drugs |
5 Armenia Pulmonary Arterial Hypertension Market Trends |
6 Armenia Pulmonary Arterial Hypertension Market, By Types |
6.1 Armenia Pulmonary Arterial Hypertension Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Armenia Pulmonary Arterial Hypertension Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Armenia Pulmonary Arterial Hypertension Market Revenues & Volume, By Endothelin Receptor Antagonists (ERAs), 2021- 2031F |
6.1.4 Armenia Pulmonary Arterial Hypertension Market Revenues & Volume, By PDE-5 Inhibitors, 2021- 2031F |
6.1.5 Armenia Pulmonary Arterial Hypertension Market Revenues & Volume, By Prostacyclin and Prostacyclin Analogs, 2021- 2031F |
6.1.6 Armenia Pulmonary Arterial Hypertension Market Revenues & Volume, By SGC Stimulators, 2021- 2031F |
6.2 Armenia Pulmonary Arterial Hypertension Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 Armenia Pulmonary Arterial Hypertension Market Revenues & Volume, By Branded, 2021- 2031F |
6.2.3 Armenia Pulmonary Arterial Hypertension Market Revenues & Volume, By Generics, 2021- 2031F |
6.3 Armenia Pulmonary Arterial Hypertension Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Armenia Pulmonary Arterial Hypertension Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Armenia Pulmonary Arterial Hypertension Market Revenues & Volume, By Intravenous/ subcutaneous, 2021- 2031F |
6.3.4 Armenia Pulmonary Arterial Hypertension Market Revenues & Volume, By Inhalational, 2021- 2031F |
7 Armenia Pulmonary Arterial Hypertension Market Import-Export Trade Statistics |
7.1 Armenia Pulmonary Arterial Hypertension Market Export to Major Countries |
7.2 Armenia Pulmonary Arterial Hypertension Market Imports from Major Countries |
8 Armenia Pulmonary Arterial Hypertension Market Key Performance Indicators |
8.1 Number of PAH awareness campaigns conducted annually |
8.2 Adoption rate of advanced diagnostic tools for PAH |
8.3 Percentage increase in PAH cases diagnosed at an early stage |
8.4 Patient satisfaction with access to PAH treatment facilities |
8.5 Rate of successful outcomes in PAH treatment therapies |
9 Armenia Pulmonary Arterial Hypertension Market - Opportunity Assessment |
9.1 Armenia Pulmonary Arterial Hypertension Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Armenia Pulmonary Arterial Hypertension Market Opportunity Assessment, By Type, 2021 & 2031F |
9.3 Armenia Pulmonary Arterial Hypertension Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10 Armenia Pulmonary Arterial Hypertension Market - Competitive Landscape |
10.1 Armenia Pulmonary Arterial Hypertension Market Revenue Share, By Companies, 2024 |
10.2 Armenia Pulmonary Arterial Hypertension Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here